jamunjar-logo
whatsapp
cartmembermenu

Beta 2 Glycoprotein 1 - IgM

Unit Test
image

Report in 24Hrs

image

At Home

Details

The IgM is used for: Suspected early APS, Patients with mild or unexplained clotting symptoms, Evaluating recurrent pregnancy losses

9291100

16% OFF

customers1000+ Booked this Test

🧪 Beta-2 Glycoprotein 1 Antibody – IgM

Parameter

Details

Full Name

Beta-2 Glycoprotein 1 Antibodies – IgM

Sample Type

Blood (Serum)

Fasting Required

❌ Not Required

Test Method

ELISA (Enzyme-Linked Immunosorbent Assay)

Department

Immunology / Autoimmune Disorders

Reporting Time

2–4 days

🧬 What Is Beta-2 Glycoprotein 1?

Beta-2 Glycoprotein 1 (β2-GP1) is a plasma protein that binds to negatively charged phospholipids on cell membranes. It plays a regulatory role in the coagulation system. In some autoimmune disorders, especially Antiphospholipid Syndrome (APS), the immune system produces autoantibodies against β2-GP1.

There are three types of β2-GP1 antibodies:

  • IgG (more specific)
  • IgM (often an early marker or low-grade indicator)
  • IgA (rarely tested, sometimes used in complex cases)

🎯 Purpose of the IgM Test

The IgM subtype may be produced earlier in the immune response or in low-grade autoimmune activity, particularly in:

  • Suspected early APS
  • Patients with mild or unexplained clotting symptoms
  • Evaluating recurrent pregnancy losses

🧠 Involved Organs and Systems

System

Impact of Antibodies

Circulatory System

Increases risk of blood clots (DVT, pulmonary embolism, stroke)

Reproductive System

Can cause miscarriage, preeclampsia, fetal growth restriction

Immune System

Reflects autoimmune dysfunction in diseases like lupus

📊 Interpretation

Result

Implication

Negative

No active production of β2-GP1 IgM; APS unlikely

Low Positive

May indicate mild autoimmune activity; could be transient

High Positive

Suggests active autoimmune process; may contribute to clinical APS diagnosis

✅ For diagnosis of APS, the antibodies must be persistently positive (12 weeks apart) and associated with clinical symptoms like thrombosis or pregnancy loss.

🩺 Associated Conditions

Condition

Relation to This Test

Antiphospholipid Syndrome (APS)

Key diagnostic marker

Systemic Lupus Erythematosus (SLE)

Often coexists with β2-GP1 antibodies

Recurrent Miscarriage

Presence of IgM/IgG linked to fetal loss

Unexplained Blood Clots

Especially in young patients without risk factors

🧪 Tests Commonly Done With It

Test

Why

β2-GP1 IgG

More specific for APS diagnosis

Anticardiolipin Antibodies (aCL)

Also produced in APS

Lupus Anticoagulant

Most specific clotting-based marker for APS

PT/INR, aPTT

Evaluate clotting system integrity

ANA Panel

Screen for coexisting autoimmune disease

Anti-dsDNA

Rule out or confirm lupus involvement

📋 Quick Summary Table

Test

Beta-2 Glycoprotein 1 IgM

System Involved

Immune, Circulatory, Reproductive

Fasting Required

❌ No

Used For

APS diagnosis, autoimmune screening, miscarriage evaluation

Positive In

APS, SLE, autoimmune clotting disorders

Repeat Testing?

Yes, after 12 weeks for confirmation in APS

Best Paired With

Lupus anticoagulant, aCL IgM/IgG, β2-GP1 IgG

✅ Recommended If You Have:

  • Unexplained clotting events (DVT, stroke)
  • Recurrent 2nd or 3rd-trimester miscarriages
  • Autoimmune diseases like lupus with vascular symptoms

How our test process works!

customers
customers